Then & Now: 20 Years and Still Going Strong
Then & Now: 20 Years and Still Going Strong
OCRF Board Member, Robin Zarel, Celebrates 20 Years as an Ovarian Cancer Survivor.
News
OCRF Research Shows that Combining Targeted Agents is Effec...
OCRF Research Shows that Combining Targeted Agents is Effective Against Ovarian Cancer
New research funded in part by OCRF has shown that combining microRNA and siRNAs may be an effective new approach to developing better targeted therapies for ovarian cancer. The research was reported in the November 2013 issue of Cancer Discovery, where the findings were also highlighted in an editorial commentary. The research was funded in … Continued
Q&A with Maria Barbolina, Ph.D.
Q&A with Maria Barbolina, Ph.D.
Dr. Maria Barbolina is a 2013 Liz Tilberis Early Career Award grant recipient. In this interview with OCRF’s Sarah DeFeo, Dr. Barolina discusses her research and what it means to receive a grant from OCRF. Sarah DeFeo: Tell us a little about yourself. Maria Barbolina: I live in Chicago now, but my life started on the … Continued
OCRF Researchers Review Preclinical Models Used in Ovarian ...
OCRF Researchers Review Preclinical Models Used in Ovarian Cancer Research
In a review article published online in Oncogene on August 12, OCRF-funded researchers provide a comprehensive review of pre-clinical models used in ovarian cancer research. The authors, including OCRF grantees Ernst Lengyel, Daniela Matei, Ken Nephew, and Joanna Burdette, explore current experimental models and reflect on the strengths and weaknesses for each method. In addition, … Continued
Ovarian Cancer Research Fund and National Sponsor QVC Expan...
Ovarian Cancer Research Fund and National Sponsor QVC Expand Woman to Woman Program
Gynecologic Cancer Patients to Receive New Support in Tampa, Fla. and in Stanford, Calif. WEST CHESTER, Pa (Thursday, July 11, 2013) —Ovarian Cancer Research Fund (OCRF) and QVC today announced two new Woman to Woman grant recipients, Moffitt Cancer Center in Tampa, Fla. and Stanford Women’s Cancer Center in Stanford, Calif. QVC united with OCRF … Continued
After Angelina: What Do You Need to Know About Ovarian and ...
After Angelina: What Do You Need to Know About Ovarian and Breast Cancer Risk?
Experts agree: “If you or a close relative has been diagnosed with ovarian cancer, speak to your doctor about getting genetic counseling.” In the wake of Angelina Jolie’s announcement that she carries a genetic mutation linked to breast and ovarian cancers, thousands of women are wondering whether they are at risk. To address their concerns, … Continued
OCRF Talk with Lin Zhang, M.D.
OCRF Talk with Lin Zhang, M.D.
In an interview, 3-time grantee Dr. Zhang discusses his research and what it means to receive an award from OCRF.
Press Release: Ovarian Cancer Advocates Praise Supreme Cour...
Press Release: Ovarian Cancer Advocates Praise Supreme Court Decision on Gene Patents
Ruling Will Give Women More Options to Learn About Genetic Risk Washington, DC—The Supreme Court ruled today that a company cannot patent naturally occurring genes, including isolated gene segments, overturning a decision made by the United States Court of Appeals for the Federal Circuit in August 2012, which upheld a patent claim on the BRCA1 … Continued
Alliance Responds to Angelina Jolie's BRCA1 Announcement
Alliance Responds to Angelina Jolie's BRCA1 Announcement
Actress Angelina Jolie recently announced that she carries a mutation in the BRCA1 gene, which makes her more likely to develop breast and ovarian cancer. In the wake of that news, many media outlets reached out to the Ovarian Cancer National Alliance for commentary and perspective. Our CEO, Calaneet Balas, wrote a letter to the … Continued
LifeIce: A Daughter's Gift of Love Becomes a Mother�...
LifeIce: A Daughter's Gift of Love Becomes a Mother's Legacy
How a daughter's homemade nutritional ice chips for her mother became LifeIce.
OCRF Research Identifies Genetic Variations Increasing Ovar...
OCRF Research Identifies Genetic Variations Increasing Ovarian Cancer Risk
As part of a huge international effort involving more than 100 institutions and genetic tests on 200,000 people, researchers have discovered dozens of signposts in DNA that can help reveal further a person’s risk for breast, ovarian or prostate cancer. The OCRF-funded Ovarian Cancer Association Consortium contributed to the ovarian cancer-related findings: five new genetic … Continued
The New York Times Publishes OCRF's Letter to the Edit...
The New York Times Publishes OCRF's Letter to the Editor 3/12/13
A frequent New York Times commenter on important ovarian cancer issues, OCRF wrote a Letter to the Editor in response to the NYT editorial, “Inadequate Treatment of Ovarian Cancer,” which was published in print and online on March 21, 2013. We are grateful for the opportunity to reach such a large audience regarding the importance of seeking … Continued